BHO Estimated Investment Need to Increase England’s Capacity to Diagnose Eligibility for an Alzheimer’s Treatment to G7 Average Capacity Levels February 7, 2024
BHO Health Economic Considerations in the Deployment of an Alzheimer’s Prevention Therapy January 30, 2024
BHO Estimates of Current Capacity for Diagnosing Alzheimer’s Disease in Sweden and the Need to Expand Specialist Numbers January 11, 2024
BHO Detection Rates of Mild Cognitive Impairment in Primary Care for the United States Medicare Population January 11, 2024
BHO Projected Savings to Canadian Provincial Budgets from Reduced Long-Term Care Home Utilization Due to a Disease-Modifying Alzheimer’s Treatment January 11, 2024
BHO The age-specific comorbidity burden of mild cognitive impairment: a US claims database study December 6, 2023
BHO Expected wait times for access to a disease-modifying Alzheimer’s treatment in England: A modelling study November 6, 2023
